Journal
NATURE REVIEWS CANCER
Volume 13, Issue 4, Pages 273-282Publisher
NATURE PORTFOLIO
DOI: 10.1038/nrc3432
Keywords
-
Categories
Funding
- Cancer Research UK
- Experimental Cancer Medicine Centre grant
- National Institute of Health Research, as a Biomedical Research Centre
- Wellcome Trust
Ask authors/readers for more resources
Malignant ascites presents a considerable clinical challenge to the management of ovarian cancer, but also provides a wealth of opportunities for translational research. The accessibility of ascitic fluid and its cellular components make it an excellent source of tumour tissue for the investigation of prognostic and predictive biomarkers, pharmacodynamic markers and for molecular profiling analysis. In this Opinion article, we discuss recent advances in our understanding of its pathophysiology, the development of new methods to characterize its molecular features and how these findings can be used to improve the treatment of malignant ascites, particularly in the context of ovarian cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available